154 related articles for article (PubMed ID: 36521881)
21. The pathway to diagnosis and treatment for surgically managed lung cancer patients.
White V; Bergin RJ; Thomas RJ; Whitfield K; Weller D
Fam Pract; 2020 Mar; 37(2):234-241. PubMed ID: 31665265
[TBL] [Abstract][Full Text] [Related]
22. Do perceived barriers to clinical presentation affect anticipated time to presenting with cancer symptoms: an ICBP study.
Donnelly C; Quaife S; Forbes L; Boylan J; Tishelman C; Gavin A
Eur J Public Health; 2017 Oct; 27(5):808-813. PubMed ID: 28957476
[TBL] [Abstract][Full Text] [Related]
23. "There's Not Enough Bodies to Do the Demand": An Exploration of Key Stakeholder Views on the Role of Health Service Capacity in Shaping Cancer Outcomes in 7 International Cancer Benchmarking Partnership Countries.
Seguin M; Morris M; McKee M; Nolte E
Int J Health Policy Manag; 2022 Jul; 11(7):1024-1034. PubMed ID: 33589567
[TBL] [Abstract][Full Text] [Related]
24. Advanced-stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross-sectional study.
Tørring ML; Falborg AZ; Jensen H; Neal RD; Weller D; Reguilon I; ; Menon U; Vedsted P
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13100. PubMed ID: 31119836
[TBL] [Abstract][Full Text] [Related]
25. Awareness of cancer symptoms and anticipated patient interval for healthcare seeking. A comparative study of Denmark and Sweden.
Hvidberg L; Lagerlund M; Pedersen AF; Hajdarevic S; Tishelman C; Vedsted P
Acta Oncol; 2016 Jul; 55(7):917-24. PubMed ID: 26882008
[TBL] [Abstract][Full Text] [Related]
26. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
Lynch C; Harrison S; Butler J; Baldwin DR; Dawkins P; van der Horst J; Jakobsen E; McAleese J; McWilliams A; Redmond K; Swaminath A; Finley CJ
Cancer Control; 2022; 29():10732748221119354. PubMed ID: 36269109
[TBL] [Abstract][Full Text] [Related]
27. Negative cancer beliefs, recognition of cancer symptoms and anticipated time to help-seeking: an international cancer benchmarking partnership (ICBP) study.
Pedersen AF; Forbes L; Brain K; Hvidberg L; Wulff CN; Lagerlund M; Hajdarevic S; Quaife SL; Vedsted P
BMC Cancer; 2018 Apr; 18(1):363. PubMed ID: 29609534
[TBL] [Abstract][Full Text] [Related]
28. International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.
Nicholson BD; Mant D; Neal RD; Hart N; Hamilton W; Shinkins B; Rubin G; Rose PW
Br J Gen Pract; 2016 Feb; 66(643):e106-13. PubMed ID: 26740607
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
[TBL] [Abstract][Full Text] [Related]
30. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
31. Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative data.
Jiang L; Lofters A; Moineddin R; Decker K; Groome P; Kendell C; Krzyzanowska M; Li D; McBride ML; Mittmann N; Porter G; Turner D; Urquhart R; Winget M; Zhang Y; Grunfeld E
Can Fam Physician; 2016 Oct; 62(10):e589-e598. PubMed ID: 27737994
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
Lüchtenborg M; Morris EJA; Tataru D; Coupland VH; Smith A; Milne RL; Te Marvelde L; Baker D; Young J; Turner D; Nishri D; Earle C; Shack L; Gavin A; Fitzpatrick D; Donnelly C; Lin Y; Møller B; Brewster DH; Deas A; Huws DW; White C; Warlow J; Rashbass J; Peake MD
Thorax; 2018 Apr; 73(4):339-349. PubMed ID: 29079609
[TBL] [Abstract][Full Text] [Related]
33. Knowledge of symptoms, time to presentation and barriers to medical help-seeking among Omani women diagnosed with breast cancer: a cross-sectional study.
Al-Azri M; Al-Baimani K; Al-Awaisi H; Al-Mandhari Z; Al-Khamayasi J; Al-Lawati Y; Panchatcharam SM
BMJ Open; 2021 Jan; 11(1):e043976. PubMed ID: 33478965
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada.
Webber C; Whitehead M; Eisen A; Holloway CMB; Groome PA
Breast Cancer Res Treat; 2021 May; 187(1):225-235. PubMed ID: 33486544
[TBL] [Abstract][Full Text] [Related]
35. A comparison of outcomes and survival between Victoria and Denmark in lung cancer surgery: opportunities for international benchmarking.
Stenger M; Jakobsen E; Wright G; Zalcberg J; Stirling RG
ANZ J Surg; 2022 May; 92(5):1050-1055. PubMed ID: 34676962
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.
Walters S; Maringe C; Butler J; Rachet B; Barrett-Lee P; Bergh J; Boyages J; Christiansen P; Lee M; Wärnberg F; Allemani C; Engholm G; Fornander T; Gjerstorff ML; Johannesen TB; Lawrence G; McGahan CE; Middleton R; Steward J; Tracey E; Turner D; Richards MA; Coleman MP;
Br J Cancer; 2013 Mar; 108(5):1195-208. PubMed ID: 23449362
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Role of Leadership in Facilitating Change to Improve Cancer Survival: An Analysis of Experiences in Seven High Income Countries in the International Cancer Benchmarking Partnership (ICBP).
Morris M; Seguin M; Landon S; McKee M; Nolte E
Int J Health Policy Manag; 2022 Sep; 11(9):1756-1766. PubMed ID: 34380203
[TBL] [Abstract][Full Text] [Related]
38. Investigations and referral for suspected cancer in primary care in New Zealand-A survey linked to the International Cancer Benchmarking Partnership.
Htun HW; Elwood JM; Ioannides SJ; Fishman T; Lawrenson R
Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28105767
[TBL] [Abstract][Full Text] [Related]
39. Is being diagnosed at a dedicated breast assessment unit associated with a reduction in the time to diagnosis for symptomatic breast cancer patients?
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Eur J Cancer Care (Engl); 2018 Jul; 27(4):e12864. PubMed ID: 29873137
[TBL] [Abstract][Full Text] [Related]
40. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
